Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ

被引:49
|
作者
Sneige, N
Lagios, MD
Schwarting, R
Colburn, W
Atkinson, E
Weber, D
Sahin, A
Kemp, B
Hoque, A
Risin, S
Sabichi, A
Boone, C
Dhingra, K
Kelloff, G
Lippman, S
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Anat Pathol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
[4] St Marys Med Sch, Breast Canc Consultat Serv, San Francisco, CA USA
[5] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[6] Tarzana Med Ctr, Dept Pathol, Tarzana, CA USA
[7] NCI, Div Canc Prevent & Control, Chemoprevent Branch, Bethesda, MD 20892 USA
[8] Eli Lilly Corp, Indiana, IN USA
关键词
ductal carcinoma in situ; nuclear grade; interobserver reproducibility; breast carcinoma;
D O I
10.1016/S0046-8177(99)90002-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Several studies have shown an association between high nuclear grade or necrosis of ductal carcinoma in situ (DCIS) lesions and the risk of local disease recurrence in patients with DCIS treated surgically with less than mastectomy. Although criteria for separating low from high nuclear grade lesions have been published, no information exists regarding interobserver reproducibility (IR). To assess IR in the classification of DCIS, six surgical pathologists from four institutions used the Lagios grading system to grade 125 DCIS lesions. Before meeting to evaluate the cases, a training set of 12 glass slides, including cases chosen to present conflicting cues for classification, was mailed to the participants with a written criteria summary. This was followed by a working session in which criteria were reviewed and agreed on. The pathologists then graded the lesions independently. The area of interest was marked on each slide before grading. After initial grading, the pathologists met again to resolve discrepant lesion classifications. A complete agreement among raters was achieved in 43 (35%) cases, with five of six raters agreeing in another 45 (36%) cases. In no case did two raters differ by more than one grade. The pairwise kappa agreement values ranged from fair:to substantial (0.30 to 0.61). Generalized kappa value indicated moderate agreement (0.46, standard error = 0.02). kappa statistics for the distinction between grades 1 and 2 and 2 and 3 were 0.29 and 0.48, respectively, (standard error = 0.02). Only one of the six raters differed significantly in scoring. With adherence to specific criteria, IR in the classification of DCIS cases can be obtained in most cases. Although these pathologists made a few grading system modifications, further refinements are needed, especially if grading will influence future therapy. HUM PATHOL 30:257-262. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 50 条
  • [41] Histologic Grading of Invasive Lobular Carcinoma: Does Use of a Two-Tiered Nuclear Grading System Improve Interobserver Variability?
    Adams, A. L.
    Chhieng, D. C.
    Bell, W. C.
    Winokur, T.
    Hameed, O.
    LABORATORY INVESTIGATION, 2009, 89 : 26A - 26A
  • [42] Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
    Adams, Amy L.
    Chhieng, David C.
    Bell, Walter C.
    Winokur, Tom
    Hameed, Omar
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2009, 13 (04) : 223 - 225
  • [43] Interobserver reproducibility of Gleason grading in prostate biopsy samples
    Bori Rita
    Salamon Ferenc
    Moczar Csaba
    Cserni Gabor
    ORVOSI HETILAP, 2013, 154 (31) : 1219 - 1225
  • [44] Interobserver reproductibility of Gleason's grading system for prostatic carcinoma
    Allsbrook, WC
    Lane, RB
    Lane, CG
    Mangold, KA
    Johnson, M
    Epstein, JI
    LABORATORY INVESTIGATION, 1997, 76 (01) : 386 - 386
  • [45] Presence of VIP system at the nuclear cell membrane in ductal breast carcinoma in situ
    Valdehita, Ana
    Carmena, M. Jose
    Arenas, M. Isabel
    RuiZ-Villaespesa, Antonio
    Valenzuela, Pedro
    Prieto, Juan C.
    Bajo, Ana M.
    VIRCHOWS ARCHIV, 2007, 451 (02) : 186 - 187
  • [46] Ductal carcinoma in situ of the breast:: the role of grading in a series of 610 patients
    Mandarà, M
    Auriemma, A
    Caldara, A
    Fiorio, E
    Giovannini, M
    Mercanti, A
    Pavarana, M
    Sava, T
    Cetto, GL
    Molino, A
    ANNALS OF ONCOLOGY, 2005, 16 : 279 - 279
  • [47] Variability in ductal carcinoma in situ grading among an international group of pathologists
    van Seijen, Maartje
    Jozwiak, Katarzyna
    Pinder, Sarah E.
    Hall, Allison
    Krishnamurthy, Savitri
    Thomas, Jeremy S. J.
    Collins, Laura
    Bijron, Jonathan
    Bart, Joost
    Cohen, Danielle
    Ng, Wen
    Stobart, Hilary
    Hudecek, Jan
    Lips, Esther H.
    Wesseling, Jelle
    CANCER RESEARCH, 2020, 80 (04)
  • [48] Grading Ductal Carcinoma in Situ of the Breast Using an Automated Proliferation Index
    Stasik, Christopher J.
    Davis, Marilyn
    Kimler, Bruce F.
    Fan, Fang
    Damjanov, Ivan
    Thomas, Patricia
    Tawfik, Ossama W.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2011, 41 (02): : 122 - 130
  • [49] Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?
    Cserni, Gabor
    Sejben, Anita
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 665 - 671
  • [50] Variability in grading of ductal carcinoma in situ among an international group of pathologists
    van Seijen, Maartje
    Jozwiak, Katarzyna
    Pinder, Sarah E.
    Hall, Allison
    Krishnamurthy, Savitri
    Thomas, Jeremy Sj
    Collins, Laura C.
    Bijron, Jonathan
    Bart, Joost
    Cohen, Danielle
    Ng, Wen
    Bouybayoune, Ihssane
    Stobart, Hilary
    Hudecek, Jan
    Schaapveld, Michael
    Thompson, Alastair
    Lips, Esther H.
    Wesseling, Jelle
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2021, 7 (03): : 233 - 242